https://ssooop.github.io/ The bilingual research and writing archive of Alex Su (苏晨鹏) on AI, biopharma, scientific software, and long-term value. zh-CN Alex Su (苏晨鹏) Mon, 27 Jul 2026 00:00:00 GMT https://ssooop.github.io/zh/blog/2026/no-silver-bullet-scientific-intelligence/cn https://ssooop.github.io/zh/blog/2026/no-silver-bullet-scientific-intelligence/cn Mon, 27 Jul 2026 00:00:00 GMT 从 Claude Science、药物研发的慢反馈、级联控制、信息增益与 Kauffman 的开放相空间出发，讨论现实科学智能如何持续进化。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/no-silver-bullet-scientific-intelligence/en https://ssooop.github.io/en/blog/2026/no-silver-bullet-scientific-intelligence/en Mon, 27 Jul 2026 00:00:00 GMT Claude Science, slow real-world feedback, cascade control, information gain, and Kauffman’s open phase space offer a framework for thinking about evolving scientific intelligence. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/returning-yielding-china-pharma/cn https://ssooop.github.io/zh/blog/2026/returning-yielding-china-pharma/cn Mon, 01 Jun 2026 00:00:00 GMT 从中国创新药BD浪潮、准市场机制、医保支付改革与资本市场转型出发，讨论中国制药行业所处的发展阶段，以及企业和本土投资者真正需要保留的长期能力。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/returning-yielding-china-pharma/en https://ssooop.github.io/en/blog/2026/returning-yielding-china-pharma/en Mon, 01 Jun 2026 00:00:00 GMT Starting from China’s innovative-drug licensing wave, quasi-market design, reimbursement reform, and capital-market transition, this essay examines the development stage of Chinese pharma and the capabilities that companies and domestic investors must preserve. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/ai-pharma-beyond-office-capital-imbalance/cn https://ssooop.github.io/zh/blog/2026/ai-pharma-beyond-office-capital-imbalance/cn Mon, 11 May 2026 00:00:00 GMT 从通用目的技术、生产率 J-Curve 与资本可占有性出发，解释 AI 为何集中在数字封闭空间，以及 AI 制药如何跨越物理—组织开放空间中的资本失衡。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/ai-pharma-beyond-office-capital-imbalance/en https://ssooop.github.io/en/blog/2026/ai-pharma-beyond-office-capital-imbalance/en Mon, 11 May 2026 00:00:00 GMT Using general-purpose technology theory, the productivity J-curve, and capital appropriability, this essay explains why AI clusters in digitally closed spaces—and how AI drug discovery can cross the capital gap in physically and organizationally open systems. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/ai-drug-discovery-company-value-logic/cn https://ssooop.github.io/zh/blog/2026/ai-drug-discovery-company-value-logic/cn Mon, 30 Mar 2026 00:00:00 GMT 从礼来与 Insilico 的合作谈起，讨论 AI 制药企业的价值为何不应被简化为单条管线成功率，以及资本情绪、组织能力与长期技术演化如何共同塑造估值。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/ai-drug-discovery-company-value-logic/en https://ssooop.github.io/en/blog/2026/ai-drug-discovery-company-value-logic/en Mon, 30 Mar 2026 00:00:00 GMT Beginning with the Lilly–Insilico collaboration, this essay explains why the value of an AI drug discovery company cannot be reduced to the success rate of a single pipeline—and how capital sentiment, organizational capability, and long-term technological change shape valuation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/participating-in-ai-pharma-evolution/cn https://ssooop.github.io/zh/blog/2026/participating-in-ai-pharma-evolution/cn Mon, 23 Mar 2026 00:00:00 GMT 从 OpenClaw 热潮、控制论四要素与中国开源生态出发，讨论 AI+制药企业如何跨越资本、治理与技术战略之间的四重矛盾。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/participating-in-ai-pharma-evolution/en https://ssooop.github.io/en/blog/2026/participating-in-ai-pharma-evolution/en Mon, 23 Mar 2026 00:00:00 GMT Beginning with the OpenClaw craze, control theory, and China’s open-source history, this essay examines the capital, governance, and technology tensions shaping AI-powered drug discovery. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/why-ai-drug-discovery-is-not-alphago/cn https://ssooop.github.io/zh/blog/2026/why-ai-drug-discovery-is-not-alphago/cn Mon, 16 Mar 2026 00:00:00 GMT 从 AlphaZero、自我对弈、工具增强型 Agent 与 Reward Hacking 出发，解释封闭世界强化学习为何无法直接跨越药物研发中的稀疏真实奖励。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/why-ai-drug-discovery-is-not-alphago/en https://ssooop.github.io/en/blog/2026/why-ai-drug-discovery-is-not-alphago/en Mon, 16 Mar 2026 00:00:00 GMT Through AlphaZero, self-play, tool-using agents, and reward hacking, this essay explains why closed-world reinforcement learning cannot directly overcome the sparse true rewards of drug development. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/predicting-pharma-innovation/cn https://ssooop.github.io/zh/blog/2026/predicting-pharma-innovation/cn Mon, 09 Mar 2026 00:00:00 GMT 从元科学、Science of Science 与自动化科研系统出发，讨论医药创新中可预测的组合规律、不可预测的突破，以及可被工程化的创新条件。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/predicting-pharma-innovation/en https://ssooop.github.io/en/blog/2026/predicting-pharma-innovation/en Mon, 09 Mar 2026 00:00:00 GMT Through metascience, the science of science, and automated research systems, this essay examines the predictable combinations, unpredictable breakthroughs, and engineerable conditions of pharmaceutical innovation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/continuous-refactoring/cn https://ssooop.github.io/zh/blog/2026/continuous-refactoring/cn Sun, 01 Mar 2026 00:00:00 GMT 以 Agent Coding 为案例，讨论自进化系统的结构、发生机制，以及 AI 时代人类劳动关系的未来走向 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/continuous-refactoring/en https://ssooop.github.io/en/blog/2026/continuous-refactoring/en Sun, 01 Mar 2026 00:00:00 GMT From Codex App Server to LUMI-lab, this essay explains why software engineering evolves quickly under AI and how the pattern may spread. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/new-year-wish-optimistic-future/cn https://ssooop.github.io/zh/blog/2026/new-year-wish-optimistic-future/cn Mon, 23 Feb 2026 00:00:00 GMT 新年寄语与深度思考，关键词包括：技术，创新，创造力，乐观主义，未来。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/new-year-wish-optimistic-future/en https://ssooop.github.io/en/blog/2026/new-year-wish-optimistic-future/en Mon, 23 Feb 2026 00:00:00 GMT A New Year reflection on technology, creativity, economic thought, and the deliberate choice to remain optimistic about the future. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/de-novo-protein-domaining/cn https://ssooop.github.io/zh/blog/2026/de-novo-protein-domaining/cn Mon, 26 Jan 2026 00:00:00 GMT 深度探讨de novo protein在生物医药中应用受限的原因，关键词包括：域定，工业革命，de novo design，系统工程。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/de-novo-protein-domaining/en https://ssooop.github.io/en/blog/2026/de-novo-protein-domaining/en Mon, 26 Jan 2026 00:00:00 GMT Why de novo protein design remains constrained in biomedicine—and how new engineering domains and biological ontologies could unlock its potential. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/ai-agent-biopharma-labor/cn https://ssooop.github.io/zh/blog/2026/ai-agent-biopharma-labor/cn Mon, 19 Jan 2026 00:00:00 GMT 深度探讨生物医药行业的AI Agent影响，关键词包括：Manus，Agent，流程解放，生产关系。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/ai-agent-biopharma-labor/en https://ssooop.github.io/en/blog/2026/ai-agent-biopharma-labor/en Mon, 19 Jan 2026 00:00:00 GMT Deep dive into AI Agent's impact on biopharma industry, keywords include: Manus, Agent, process liberation, production relations. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/ai-pharma-product-company/cn https://ssooop.github.io/zh/blog/2026/ai-pharma-product-company/cn Mon, 12 Jan 2026 00:00:00 GMT 深度探讨AI+制药产品型企业的议价权逻辑，关键词包括：议价权，网络杠杆，资本杠杆，竞争区间。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/ai-pharma-product-company/en https://ssooop.github.io/en/blog/2026/ai-pharma-product-company/en Mon, 12 Jan 2026 00:00:00 GMT Deep dive into the bargaining power logic of AI+pharma product companies, keywords include: bargaining power, network leverage, capital leverage, competitive landscape. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2026/ai-platform-complexity-burden/cn https://ssooop.github.io/zh/blog/2026/ai-platform-complexity-burden/cn Mon, 05 Jan 2026 00:00:00 GMT 深度探讨AI平台的成本经济学与交易成本理论，关键词包括：AI Agent，交易成本，复杂度分配，企业边界。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2026/ai-platform-complexity-burden/en https://ssooop.github.io/en/blog/2026/ai-platform-complexity-burden/en Mon, 05 Jan 2026 00:00:00 GMT Deep dive into AI platform cost economics and transaction cost theory, keywords include: AI Agent, transaction cost, complexity allocation, firm boundaries. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/nl-201-de-novo-design/cn https://ssooop.github.io/zh/blog/2025/nl-201-de-novo-design/cn Mon, 29 Dec 2025 00:00:00 GMT 深度探讨de novo蛋白的商业化之路，关键词包括：NL-201，de novo design，临床需求 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/nl-201-de-novo-design/en https://ssooop.github.io/en/blog/2025/nl-201-de-novo-design/en Mon, 29 Dec 2025 00:00:00 GMT A look back at NL-201, Neoleukin, and what de novo protein design teaches about clinical validation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-pharma-holistic-flexibility/cn https://ssooop.github.io/zh/blog/2025/ai-pharma-holistic-flexibility/cn Mon, 22 Dec 2025 00:00:00 GMT 深度探讨AI制药的软系统工程方法论，关键词包括：系统工程，软系统，知识合成 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-pharma-holistic-flexibility/en https://ssooop.github.io/en/blog/2025/ai-pharma-holistic-flexibility/en Mon, 22 Dec 2025 00:00:00 GMT A systems-engineering view of AI drug discovery, contrasting hard systems with softer biological and organizational realities. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-pharma-product-form/cn https://ssooop.github.io/zh/blog/2025/ai-pharma-product-form/cn Mon, 15 Dec 2025 00:00:00 GMT 深度探讨AI制药的产品形态革命，关键词包括：产品形态，SaaS模式，Genentech，监管风险 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-pharma-product-form/en https://ssooop.github.io/en/blog/2025/ai-pharma-product-form/en Mon, 15 Dec 2025 00:00:00 GMT An essay on whether AI drug discovery companies are selling tools, platforms, services, or productized therapeutic capability. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-pharma-cultural-journey/cn https://ssooop.github.io/zh/blog/2025/ai-pharma-cultural-journey/cn Mon, 08 Dec 2025 00:00:00 GMT 深度探讨AI制药的文化重组方式，关键词包括：组织文化，AI+制造，丰田文化 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-pharma-cultural-journey/en https://ssooop.github.io/en/blog/2025/ai-pharma-cultural-journey/en Mon, 08 Dec 2025 00:00:00 GMT An essay on why AI drug discovery needs organizational and industrial culture change, not only better models. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-drug-target-discovery-pocket/cn https://ssooop.github.io/zh/blog/2025/ai-drug-target-discovery-pocket/cn Mon, 01 Dec 2025 00:00:00 GMT 深度探讨AI制药的靶点/疗法创新逻辑，关键词包括：不可成药靶点，Therapy发现 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-drug-target-discovery-pocket/en https://ssooop.github.io/en/blog/2025/ai-drug-target-discovery-pocket/en Mon, 01 Dec 2025 00:00:00 GMT A reflection on undruggable targets, newly discovered pockets, and why AI drug discovery should return to therapy-level innovation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-pharma-pipeline-valuation/cn https://ssooop.github.io/zh/blog/2025/ai-pharma-pipeline-valuation/cn Mon, 24 Nov 2025 00:00:00 GMT 深入分析AI制药管线的估值逻辑，从rNPV模型到实际BD交易案例，探讨AI制药在产业端的真实价值 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-pharma-pipeline-valuation/en https://ssooop.github.io/en/blog/2025/ai-pharma-pipeline-valuation/en Mon, 24 Nov 2025 00:00:00 GMT A practical discussion of AI drug discovery pipeline valuation, from rNPV models to business development transaction logic. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-pharma-long-term-value-investing/cn https://ssooop.github.io/zh/blog/2025/ai-pharma-long-term-value-investing/cn Mon, 17 Nov 2025 00:00:00 GMT 从资本泡沫到价值逻辑，深入分析AI制药领域的投资哲学与技术革命的本质关系 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-pharma-long-term-value-investing/en https://ssooop.github.io/en/blog/2025/ai-pharma-long-term-value-investing/en Mon, 17 Nov 2025 00:00:00 GMT From AI capital cycles to durable value, this essay asks how to think about AI drug discovery beyond the bubble. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/interaction-zen-reinventing-experts/cn https://ssooop.github.io/zh/blog/2025/interaction-zen-reinventing-experts/cn Mon, 10 Nov 2025 00:00:00 GMT 探讨AI时代人机交互的范式转变，从历史演进到未来展望，审视生产力与生产关系的深层变革 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/interaction-zen-reinventing-experts/en https://ssooop.github.io/en/blog/2025/interaction-zen-reinventing-experts/en Mon, 10 Nov 2025 00:00:00 GMT A historical and theoretical reflection on human-computer interaction, AI-native UX, and how expertise changes in the AI era. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/lilly-ai-innovation-dilemma/cn https://ssooop.github.io/zh/blog/2025/lilly-ai-innovation-dilemma/cn Mon, 03 Nov 2025 00:00:00 GMT 深度探讨巨头Lilly的AI战略和创新者窘境理论，关键词包括：Lilly的AI战略、延续性创新、破坏性创新、技术驱动商业模式。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/lilly-ai-innovation-dilemma/en https://ssooop.github.io/en/blog/2025/lilly-ai-innovation-dilemma/en Mon, 03 Nov 2025 00:00:00 GMT What Lilly's Blackwell supercomputer reveals about big pharma's AI strategy—and why better models may be sustaining rather than disruptive innovation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/rebuild-it-ai-pharma/cn https://ssooop.github.io/zh/blog/2025/rebuild-it-ai-pharma/cn Mon, 27 Oct 2025 00:00:00 GMT 深度探讨AI驱动制药的AI/IT部门形态，关键词包括：DevOps三步工作法、学习型组织、复杂度革命。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/rebuild-it-ai-pharma/en https://ssooop.github.io/en/blog/2025/rebuild-it-ai-pharma/en Mon, 27 Oct 2025 00:00:00 GMT Explore the AI/IT department structure in AI-driven pharmaceutical industry, with keywords including: DevOps Three Ways, Learning Organization, Complexity Revolution. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/break-newbie-month-effect/cn https://ssooop.github.io/zh/blog/2025/break-newbie-month-effect/cn Mon, 20 Oct 2025 00:00:00 GMT 深度探讨AI时代下系统复杂度革新和原生组织形态，关键词包括：人月效应、AI原生组织、系统复杂度、生产力革新。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/break-newbie-month-effect/en https://ssooop.github.io/en/blog/2025/break-newbie-month-effect/en Mon, 20 Oct 2025 00:00:00 GMT Explore the system complexity revolution and native organizational forms in the AI era, with keywords including: Man-Month Myth, AI-Native Organization, System Complexity, Productivity Innovation. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/spec-coding-rethinking-code-assets/cn https://ssooop.github.io/zh/blog/2025/spec-coding-rethinking-code-assets/cn Mon, 13 Oct 2025 00:00:00 GMT 深度探讨AI Coding的概念性革新Spec Coding的非共识，关键词包括：Spec Coding、代码资产、抽象层次、AI+行业模式 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/spec-coding-rethinking-code-assets/en https://ssooop.github.io/en/blog/2025/spec-coding-rethinking-code-assets/en Mon, 13 Oct 2025 00:00:00 GMT A reflection on vibe coding, spec coding, and how AI changes the asset structure of software and industry workflows. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/lilly-ai-strategy/cn https://ssooop.github.io/zh/blog/2025/lilly-ai-strategy/cn Mon, 29 Sep 2025 00:00:00 GMT 深度探讨制药巨头Lilly的AI转型策略，关键词包括：AI转型、AI原生组织、数据生态 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/lilly-ai-strategy/en https://ssooop.github.io/en/blog/2025/lilly-ai-strategy/en Mon, 29 Sep 2025 00:00:00 GMT An analysis of Eli Lilly's AI strategy, from external partnerships to internal capability building and ecosystem design. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/hallucination-experience-boundary/cn https://ssooop.github.io/zh/blog/2025/hallucination-experience-boundary/cn Mon, 22 Sep 2025 00:00:00 GMT 深度探讨LLM的Hallucination现象的研究范式之思，关键词包括：Hallucination、Reinforcement Learning、Experience zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/hallucination-experience-boundary/en https://ssooop.github.io/en/blog/2025/hallucination-experience-boundary/en Mon, 22 Sep 2025 00:00:00 GMT A reflection on hallucination, AlphaGo, and whether AI-generated deviations can expand scientific experience rather than merely create errors. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/protein-docking-context/cn https://ssooop.github.io/zh/blog/2025/protein-docking-context/cn Mon, 15 Sep 2025 00:00:00 GMT 深度探讨Protein Docking真实应用中的模型Formulation，关键词包括：Ab-Ag Docking、Structure Assembly、Binding Dynamics zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/protein-docking-context/en https://ssooop.github.io/en/blog/2025/protein-docking-context/en Mon, 15 Sep 2025 00:00:00 GMT A discussion of protein docking in real antibody development contexts, including Ab-Ag docking, structure assembly, and binding dynamics. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/agent-workflow-charm/cn https://ssooop.github.io/zh/blog/2025/agent-workflow-charm/cn Mon, 08 Sep 2025 00:00:00 GMT 深度探讨Agent和Workflow技术中的架构设计原则，关键词包括：Agent Workflow、Agent Planning、Dify、n8n zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/agent-workflow-charm/en https://ssooop.github.io/en/blog/2025/agent-workflow-charm/en Mon, 08 Sep 2025 00:00:00 GMT A discussion of why agents and workflows are not opposing paradigms, but complementary layers in reliable AI application architecture. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/ai-native-research-system/cn https://ssooop.github.io/zh/blog/2025/ai-native-research-system/cn Mon, 01 Sep 2025 00:00:00 GMT 深度探讨Agent商业化与AI Scientist落地，关键词包括：Agent商业化、AI Scientist、AI Native Reseach System zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/ai-native-research-system/en https://ssooop.github.io/en/blog/2025/ai-native-research-system/en Mon, 01 Sep 2025 00:00:00 GMT A proposal for research systems designed around AI strengths, with coding agents and deep research agents as reference cases. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/glp1-china-giants-battle/cn https://ssooop.github.io/zh/blog/2025/glp1-china-giants-battle/cn Mon, 25 Aug 2025 00:00:00 GMT 深度解析国产GLP-1研发格局，探讨中国BioTech如何在红海市场中实现差异化突围。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/glp1-china-giants-battle/en https://ssooop.github.io/en/blog/2025/glp1-china-giants-battle/en Mon, 25 Aug 2025 00:00:00 GMT How Chinese biotechs can differentiate in the crowded GLP-1 market through comorbidity strategies, muscle preservation, and better product design. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/aidd-anti-internal-roll/cn https://ssooop.github.io/zh/blog/2025/aidd-anti-internal-roll/cn Mon, 18 Aug 2025 00:00:00 GMT 从外卖三国杀大战分析医药行业竞争格局，探讨AIDD如何成为反内卷的驱动力。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/aidd-anti-internal-roll/en https://ssooop.github.io/en/blog/2025/aidd-anti-internal-roll/en Mon, 18 Aug 2025 00:00:00 GMT What China's food-delivery subsidy war reveals about destructive competition in pharma—and how AIDD could shift competition toward genuine productivity. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/glp1-weight-loss-battle/cn https://ssooop.github.io/zh/blog/2025/glp1-weight-loss-battle/cn Mon, 11 Aug 2025 00:00:00 GMT 深度解析诺和诺德与礼来在GLP-1减肥药市场的世纪竞争，探讨先发者为何遭遇致命失误，双靶点如何实现红海突围。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/glp1-weight-loss-battle/en https://ssooop.github.io/en/blog/2025/glp1-weight-loss-battle/en Mon, 11 Aug 2025 00:00:00 GMT How Novo Nordisk's first-mover advantage collided with supply constraints—and how Lilly used dual agonism and manufacturing capacity to catch up. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/software-engineering-hdd/cn https://ssooop.github.io/zh/blog/2025/software-engineering-hdd/cn Fri, 08 Aug 2025 00:00:00 GMT 从Figma的协作模式到人月神话，探讨软件工程如何启发整体药物开发(HDD)的实现路径。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/software-engineering-hdd/en https://ssooop.github.io/en/blog/2025/software-engineering-hdd/en Fri, 08 Aug 2025 00:00:00 GMT How Figma, Brooks's Law, and loose coupling reveal a practical architecture for AI-enabled Holistic Drug Development. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/protein-design-plasmid/cn https://ssooop.github.io/zh/blog/2025/protein-design-plasmid/cn Mon, 04 Aug 2025 00:00:00 GMT 探讨Chai-2模型突破带来的蛋白质设计新范式，分析AIDD在抗体发现领域的非价格竞争发展方向。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/protein-design-plasmid/en https://ssooop.github.io/en/blog/2025/protein-design-plasmid/en Mon, 04 Aug 2025 00:00:00 GMT How Chai-2 exposes the plasmid-library bottleneck in antibody design—and why generative models must converge with experimental screening. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/palantir-aidd-paradigm-shift/cn https://ssooop.github.io/zh/blog/2025/palantir-aidd-paradigm-shift/cn Sun, 03 Aug 2025 00:00:00 GMT 探讨AI Agent在重资产行业（如制药）的商业化落地路径，解析Palantir模式对AIDD的借鉴意义。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/palantir-aidd-paradigm-shift/en https://ssooop.github.io/en/blog/2025/palantir-aidd-paradigm-shift/en Sun, 03 Aug 2025 00:00:00 GMT What Palantir's Ontology and project-delivery model can teach AIDD companies about commercializing AI in a capital-intensive industry. en-US Alex Su (苏晨鹏) https://ssooop.github.io/zh/blog/2025/from-drug-to-medicine/cn https://ssooop.github.io/zh/blog/2025/from-drug-to-medicine/cn Sun, 27 Jul 2025 00:00:00 GMT 从drug与medicine的语义差异出发，讨论AIDD如何从模型性能叙事回到临床未满足需求，并重新理解药物发现的伦理坐标。 zh-CN Alex Su (苏晨鹏) https://ssooop.github.io/en/blog/2025/from-drug-to-medicine/en https://ssooop.github.io/en/blog/2025/from-drug-to-medicine/en Sun, 27 Jul 2025 00:00:00 GMT Starting from the semantic gap between drug and medicine, this essay asks how AIDD can move beyond model-performance narratives and return to clinically unmet needs. en-US Alex Su (苏晨鹏)